L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
70,100
-2,300 (-3.18%)
Apr 28, 2026, 3:30 PM KST
227.57%
Market Cap 1.74T
Revenue (ttm) 85.48B
Net Income (ttm) -138.17B
Shares Out 24.85M
EPS (ttm) -5,819.37
PE Ratio n/a
Forward PE n/a
Dividend 50.00 (0.07%)
Ex-Dividend Date Dec 29, 2025
Volume 203,333
Average Volume 198,768
Open 72,000
Previous Close 72,400
Day's Range 69,500 - 72,000
52-Week Range 20,800 - 125,000
Beta 1.61
RSI 47.28
Earnings Date Mar 24, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.